Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 538

1.

Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study.

Mumford JL, Wu K, Xia Y, Kwok R, Yang Z, Foster J, Sanders WE.

Environ Health Perspect. 2007 May;115(5):690-4. Epub 2007 Feb 14.

2.

Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients.

Nakao S, Hatano K, Sumi C, Masuzawa M, Sakamoto S, Ikeda S, Shingu K.

Anesth Analg. 2010 Mar 1;110(3):775-9. doi: 10.1213/ANE.0b013e3181cde713.

PMID:
20185656
3.
4.

Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia.

Guo X, Liu Z, Huang C, You L.

J Health Popul Nutr. 2006 Jun;24(2):214-20.

PMID:
17195562
5.

Frequency and prognostic significance of QT prolongation in chronic renal failure patients.

Voiculescu M, Ionescu C, Ismail G.

Rom J Intern Med. 2006;44(4):407-17.

PMID:
18386617
6.

The effect of arsenic trioxide on QT interval prolongation during APL therapy.

Zhou J, Meng R, Li X, Lu C, Fan S, Yang B.

Chin Med J (Engl). 2003 Nov;116(11):1764-6.

PMID:
14642155
8.

Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.

Hulhoven R, Rosillon D, Bridson WE, Meeus MA, Salas E, Stockis A.

Clin Ther. 2008 Feb;30(2):260-70. doi: 10.1016/j.clinthera.2008.02.002.

PMID:
18343264
9.

T wave "humps" as a potential electrocardiographic marker of the long QT syndrome.

Lehmann MH, Suzuki F, Fromm BS, Frankovich D, Elko P, Steinman RT, Fresard J, Baga JJ, Taggart RT.

J Am Coll Cardiol. 1994 Sep;24(3):746-54.

10.

Effect of arsenic trioxide on QT interval in patients with advanced malignancies.

Barbey JT, Pezzullo JC, Soignet SL.

J Clin Oncol. 2003 Oct 1;21(19):3609-15.

PMID:
14512391
11.

Sympathomimetic infusion and cardiac repolarization: the normative effects of epinephrine and isoproterenol in healthy subjects.

Magnano AR, Talathoti N, Hallur R, Bloomfield DM, Garan H.

J Cardiovasc Electrophysiol. 2006 Sep;17(9):983-9. Epub 2006 Jul 18.

PMID:
16879629
12.
13.

Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey.

Benoit SR, Mendelsohn AB, Nourjah P, Staffa JA, Graham DJ.

Eur J Cardiovasc Prev Rehabil. 2005 Aug;12(4):363-8.

PMID:
16079644
14.

T wave alternans in idiopathic long QT syndrome.

Zareba W, Moss AJ, le Cessie S, Hall WJ.

J Am Coll Cardiol. 1994 Jun;23(7):1541-6.

15.

The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group.

Veglio M, Borra M, Stevens LK, Fuller JH, Perin PC.

Diabetologia. 1999 Jan;42(1):68-75.

PMID:
10027581
16.

Electrocardiographic abnormalities among arsenic-exposed persons through groundwater in Bangladesh.

Ahmad SA, Khatun F, Sayed MH, Khan MH, Aziz R, Hossain MZ, Faruquee MH.

J Health Popul Nutr. 2006 Jun;24(2):221-7.

PMID:
17195563
17.

Prevalence of long QTc interval in methadone maintenance patients.

Fonseca F, Marti-Almor J, Pastor A, Cladellas M, Farré M, de la Torre R, Torrens M.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):327-32. doi: 10.1016/j.drugalcdep.2008.06.018. Epub 2008 Sep 5.

PMID:
18774239
18.

Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases.

Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G, Galeazzi M, Marcolongo R, Laghi-Pasini F.

Arthritis Rheum. 2004 Apr;50(4):1248-52.

19.

Prevalence of QTc prolongation in adult Nigerians with chronic heart failure.

Kolo PM, Opadijo OG, Omotoso AB, Balogun MO, Araoye MA, Katibi IA.

West Afr J Med. 2008 Apr;27(2):69-73.

PMID:
19025017
20.

[Effect of the tetra-arsenic tetra-sulfide (As4S4) on the corrected QT interval in the treatment of acute promyelocytic leukemia].

Shen JC, Liu KY, Jiang B, Lu XJ, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2004 Jun;25(6):359-61. Chinese.

PMID:
15308017

Supplemental Content

Support Center